58 devices · GMDN 57515
This category of in vitro diagnostic (IVD) devices uses antibodies to detect the presence of p53 tumour protein in clinical specimens. The p53 protein is often associated with cancer, and these devices help clinicians identify and understand its role in various diseases. These IVDs are designed to bind to specific parts of the p53 protein, allowing for qualitative and quantitative analysis. This information can be crucial in diagnosis, treatment, and research.
When browsing this category, it's essential to understand that these devices are subject to regulatory oversight due to their intended use in detecting a specific protein in clinical specimens. The devices typically involve immunoglobulins, such as monoclonal antibodies, which are designed to target specific antigenic determinants on the p53 protein. As with other IVDs, the supply and regulation of these devices are critical to ensuring their safety and effectiveness in clinical settings.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.